Table 2.
Neurodevelopmental outcome.
| Total (n = 87) | Mildly abnormal development (n = 15) | Severe brain injury (n = 15) | |
|---|---|---|---|
| Epilepsy | 8 | – | 8 |
| Visual impairment | 2 | – | 2 |
| Hearing deficit | 2 | – | 2 |
| Cerebral palsy | 2 | – | 2 |
| Microcephaly | 3 | – | 3 |
| Signs of brain injury in MRI scans (n = 24) | 7 | – | 7 |
| Abnormal EEG (n = 32) | 13* | 3 | 9 |
| Neurodevelopmental delay | 28 | 15 | 13 |
| ≤2 areas | 21 | 15 | 6 |
| ≥3 areas | 7 | – | 7 |
| - Speech | 9 | 6 | 3 |
| - Psychiatric/behavioral | 8 | 5 | 3 |
| - Cognition | 2 | 0 | 2 |
| - Motor | 16 | 9 | 7 |
| - Global | 4 | – | 4 |
| Severe mental retardation | 2 | – | 2 |
| - ADD/ADHD | 2 | 2 | 0 |
| - Hyperactivity/attention deficit (no AD(H)D diagnosis) | 7 | 4 | 3 |
| Neurocognitive testing | 21 | 8 | 8 |
Data are presented as number. *Including one child without abnormal neurodevelopment. MRI, magnetic resonance imaging; EEG, electroencephalography; (AD(H)D), attention deficit (hyperactivity) disorder.